KALA BIO Inc. (KALA)
NASDAQ: KALA
· Real-Time Price · USD
1.54
0.00 (0.00%)
At close: Oct 03, 2025, 3:59 PM
1.54
0.00%
After-hours: Oct 03, 2025, 07:51 PM EDT
KALA BIO Revenue Breakdown
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|
| Sales discounts and contractual fee for service arrangements Revenue | 20K | 2.06M | 1.54M |
| Sales discounts and contractual fee for service arrangements Revenue Growth | -99.03% | +33.70% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.64M | 4.59M | 4.2M | 4.4M | 4.32M | 5.42M | 4.55M | 4.79M | 4.96M | 6.03M | 5.83M | 9.55M | 22.67M | 26.98M | 24.03M | 25.35M | 27.99M | 27.7M | 26.47M | 23.89M | 15.3M | 15.41M | 14.49M | 15.28M | 17.01M | 18.24M | 14.33M | 8.47M | 7.15M | 5.48M | 5.26M | 2.52M | 1.56M | 1.53M | 3.07M | 1.49M | 1.91M | 1.17M | 1.04M |
| Selling, General, and Administrative Revenue Growth | +1.09% | +9.33% | -4.52% | +1.92% | -20.38% | +19.09% | -5.05% | -3.37% | -17.71% | +3.41% | -38.94% | -57.88% | -15.97% | +12.30% | -5.22% | -9.42% | +1.04% | +4.66% | +10.77% | +56.15% | -0.69% | +6.32% | -5.16% | -10.15% | -6.74% | +27.27% | +69.19% | +18.43% | +30.45% | +4.22% | +109.06% | +61.39% | +1.76% | -50.15% | +106.10% | -21.98% | +64.03% | +12.13% | n/a |
| Research and Development Revenue | 6.23M | 6.05M | 5.19M | 5.17M | 5.26M | 6.35M | 4.72M | 5.55M | 4.28M | 4.04M | 3.32M | 5.39M | 4.47M | 4.47M | 2.41M | 2.88M | 3.09M | 3.13M | 3.4M | 3.47M | 6.05M | 5.43M | 6.14M | 7.07M | 7.11M | 6.96M | 9.24M | 7.03M | 7.37M | 5.66M | 5.88M | 7.02M | 8.07M | 8.04M | 6.91M | 8.26M | 5.95M | 3.91M | 3.83M |
| Research and Development Revenue Growth | +2.92% | +16.69% | +0.41% | -1.67% | -17.24% | +34.61% | -15.05% | +29.83% | +6.00% | +21.46% | -38.36% | +20.52% | +0.16% | +85.00% | -16.21% | -6.88% | -1.02% | -7.98% | -2.05% | -42.71% | +11.39% | -11.47% | -13.18% | -0.53% | +2.14% | -24.68% | +31.48% | -4.63% | +30.25% | -3.79% | -16.22% | -13.05% | +0.40% | +16.30% | -16.28% | +38.76% | +52.14% | +2.06% | n/a |